New Zealand markets open in 8 hours 27 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9200-0.1700 (-8.13%)
At close: 04:00PM EST
1.9200 0.00 (0.00%)
Pre-market: 07:01AM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.0900
Bid1.9000 x 45100
Ask1.9200 x 36900
Day's range1.9000 - 2.1500
52-week range1.9000 - 11.1000
Avg. volume4,083,411
Market cap227.347M
Beta (5Y monthly)1.58
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    2 Cancer Stocks With Absurdly Low Valuations

    The potential for four or more interest rate hikes by the Federal Reserve over the course of 2022 has been weighing heavily on growth stocks of late. Investors are clearly pivoting toward safe havens like value and dividend stocks ahead of this perceived eventuality. Shares of the cancer specialists Adaptimmune Therapeutics (NASDAQ: ADAP) and Clovis Oncology (NASDAQ: CLVS) are both trading at absurdly low valuations following their steep downturns over the past several weeks.

  • Zacks

    Is the Options Market Predicting a Spike in Clovis Oncology (CLVS) Stock?

    Investors need to pay close attention to Clovis Oncology (CLVS) stock based on the movements in the options market lately.

  • Zacks

    Why Is Clovis (CLVS) Down 32% Since Last Earnings Report?

    Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.